Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00339092 · ClinicalTrials.gov registry record · NA
Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT00339092: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00339092 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00339092, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of a modified directly observed therapy program in increasing antiretroviral therapy adherence in poor, HIV-infected residents of urban communities.
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL Modified Directly Observed Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00339092
The ClinicalTrials.gov registry entry for NCT00339092 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT00339092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00339092 about?
NCT00339092 is a clinical study titled "Modified Directly Observed Therapy for Improving Antiretroviral Therapy Adherence in People With HIV". This study will evaluate the effectiveness of a modified directly observed therapy program in increasing antiretroviral therapy adherence in poor, HIV-infected residents of urban communities.
What is the current status of trial NCT00339092?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2003-01. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00339092?
The interventions under investigation include: Standard Care (BEHAVIORAL), Modified Directly Observed Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00339092?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.